As of December 15, 2025, EVIO Inc (EVIO) reports a Gross Margin of 16.46%.
Gross Margin indicates the portion of sales revenue remaining after covering production costs, highlighting operational efficiency.
Historical Trend of EVIO Inc's Gross Margin
Over recent years, EVIO Inc's Gross Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Gross Margin |
|---|---|
| 2021-09-30 | 16.46% |
| 2020-09-30 | 4.14% |
| 2019-09-30 | -24.70% |
| 2018-09-30 | -14.02% |
| 2017-09-30 | 18.69% |
This slight upward trend highlights how EVIO Inc manages its operational efficiency and pricing power over time.
Comparing EVIO Inc's Gross Margin to Peers
To better understand EVIO Inc's position, it's useful to compare its Gross Margin against industry peers. Below are selected comparisons:
| Company | Gross Margin |
|---|---|
| EVIO Inc (EVIO) | 16.46% |
| Abcellera Biologics Inc (ABCL) | 7775.20% |
| Inotiv Inc (BASI) | 3015.93% |
| Rockport Capital Corp (RP.V) | 100.00% |
| Quick-Med Technologies Inc (QMDT) | 97.31% |
| Codexis Inc (CDXS) | 72.55% |
Compared to its competitors, EVIO Inc's Gross Margin is among the lowest compared to peers, suggesting potential challenges in production costs or pricing strategy.